PedAM
Pediatric Disease Annotations & Medicines
| Disease | sclerosing cholangitis |
| Phenotype | C0009402|colorectal cancer |
| Sentences | 4 |
| PubMedID- 26061393 | Background: histomorphology of colitis-associated colorectal cancer (cac) in patients with primary sclerosing cholangitis (psc) remains to be systemically characterized and prognosis in these patient needs to be further defined. |
| PubMedID- 22221173 | Conclusions: long-term high dose ursodeoxycholic acid does not prevent colorectal cancer or dysplasia in patients with primary sclerosing cholangitis-associated inflammatory bowel disease. |
| PubMedID- 25636976 | colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease. |
| PubMedID- 23665966 | We performed a systematic review and meta-analysis of studies evaluating the effect of udca on the risk of ibd-associated colorectal neoplasia (crn) (defined as colorectal cancer and/or dysplasia) in patients with primary sclerosing cholangitis with concomitant ibd (psc-ibd). |
Page: 1